Jonathan Tsang received his B.S. degree in Chemical Biology at UC Berkeley. He is currently studying EGFR signaling in glioblastoma (GBM) and how EGFR can impact the initiation and development of GBM. He is also developing novel, brain-penetrant EGFR tyrosine kinase inhibitors that can be used to treat GBM.

Associated Faculty

David Nathanson, Ph.D.Lab website